Locking Down the Airwaves for Tomorrow’s 5G Boom

One of America’s telecom giants just committed $23 billion to secure prime spectrum that could reshape the 5G landscape. With coverage set to expand into nearly every U.S. market, this move might create a long-term edge that the market isn’t fully pricing in. Here’s why this stock deserves a closer look today.

Some stocks crumble under pressure… others rise above it. In our latest free report, you’ll discover 7 companies that not only endure volatile markets—but often thrive in them.

We focus on businesses with:

• Expanding revenue streams in high-growth industries
• Strategies designed to outperform in challenging economies
• Strong potential to deliver above-market returns

This report arms you with the knowledge to navigate the months ahead with confidence.

Secure your copy before these opportunities move out of reach.

[Download Your Free Report]

Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.

Email’s great. Texts are faster.

👉 Click here to get our pre-market report to your cell for free!

You’ll be first in line when the market starts moving.

Premarket Earnings:

Aftermarket Earnings:

Economic Reports:

CVS Health (NYSE: CVS) has been one of the rare bright spots in a volatile healthcare market this year. The retail pharmacy and insurance giant has seen its stock climb more than 60% year to date, hitting fresh 52-week highs around $72 before a modest pullback in premarket trading.

The company has been working to repair its Aetna managed care business, which had weighed on results last year, while leaning into the stability of its pharmacy division. With competitors like Walgreens shuttering stores and Rite Aid facing bankruptcy, CVS has strengthened its position as the sector’s dominant retail pharmacy player.

The latest quarter offered evidence of that momentum. Revenue and earnings both topped expectations, prompting management to raise full-year guidance, a sharp contrast to 2024 when outlooks were cut multiple times.

Analysts note that CVS is benefiting not only from improved performance in its insurance arm but also from steady traffic and strong demand in its pharmacy operations, which have taken share as rivals retrench.

With a nearly 3.7% dividend yield and a valuation still below historic averages, CVS offers investors a combination of defensive stability and upside potential. The broader healthcare space continues to wrestle with policy uncertainty and tariff pressures, but CVS has proven resilient.

CVS isn’t a hyper-growth story, but its scale, market share gains, and dividend make it a compelling core holding. If management can sustain improvements at Aetna, the stock could continue rewarding patient investors.

Interactive Brokers (NASDAQ: IBKR), one of the world’s largest electronic trading platforms, just scored a milestone: inclusion in the S&P 500 index. The move, which replaces Walgreens Boots Alliance following its pending privatization, immediately boosted IBKR shares more than 4% in premarket trading.

With a $106 billion market cap and year-to-date gains of 38%, the company now meets the size and visibility thresholds required for the benchmark index.

The S&P 500 addition is more than symbolic. Inclusion typically draws automatic buying from index funds and ETFs, increasing liquidity and often supporting valuations.

For Interactive Brokers, which generates revenue through trade commissions, margin lending, and interest income on client balances, the timing is favorable. Elevated market volatility and rising retail participation in global equities have bolstered its results.

The firm has been steadily outpacing peers thanks to its low-cost trading model and expanding global footprint.

Investors will be watching to see whether the index effect provides a sustained tailwind or just a short-term pop. The stock has already delivered outsized returns in 2025, but greater institutional ownership could provide additional stability and further upside.

IBKR’s inclusion in the S&P 500 solidifies its status as a core player in U.S. finance. While the stock isn’t cheap, the structural shift toward digital brokerage platforms suggests the rally could have room to run. Dips tied to broader market swings may be worth buying.

When’s the last time you got to see a millionaire trader place a live trade—right in front of you?

On Wednesday, August 27th @ 2 P.M. ET, Nate Bear is going live for the very first 10X Lotto Trade Summit.

During this free event, you’ll discover the strategy he used to turn $37K into $2.7M.

You’ll see how he spots low-cost setups that can turn a couple hundred dollars into thousands.

And most importantly, you’ll watch him place a trade live—so you can see how his process works from start to finish.

This isn’t a theory class.

It’s real-world trading, with real setups, and real opportunity.

If you’ve ever wanted to learn how to potentially turn a tiny stake into a meaningful gain—without risking a fortune—this is your chance.

Click here to save your free seat now.

AT&T (NYSE: T) is doubling down on its connectivity ambitions with a $23 billion deal to acquire spectrum licenses from EchoStar, adding both mid-band and low-band assets that cover more than 400 U.S. markets.

The acquisition is designed to strengthen AT&T’s 5G and fixed wireless offerings, while complementing its nationwide fiber rollout. Shares rose nearly 1% in premarket trading, as investors welcomed the move despite its hefty price tag.

The deal is strategically significant because it positions AT&T to better compete with Verizon and T-Mobile in providing broad coverage and high-capacity 5G service.

The mid-band spectrum, in particular, is seen as critical for powering next-generation applications from AI-enabled devices to autonomous vehicles. AT&T also renewed a wholesale network services agreement with EchoStar, allowing it to continue generating revenue from the Boost Mobile brand.

Financially, the transaction will push leverage higher in the short term, with net debt-to-EBITDA expected to rise to around 3x.

However, management reiterated full-year 2025 guidance and maintained a $20 billion share buyback plan through 2027. The company expects the acquisition to become accretive to earnings and free cash flow by the third year after closing.

AT&T’s move is less about near-term profits and more about securing the spectrum needed for the next wave of wireless growth.

Investors seeking a balance of yield and long-term 5G potential may find this dip-buying opportunity appealing.

Super X AI Technology (SUPX), a small-cap firm specializing in advanced AI server hardware, has been one of 2025’s most dramatic movers. The stock is up nearly 1,500% this year and jumped another 7% premarket after launching a new server built on cutting-edge Nvidia chips. Investors see the product as a potential gateway into the fast-expanding AI infrastructure market, where demand for compute power continues to surge.

While Q2 revenue rose 40% year over year to $2.9 million, the company is still losing money and trades at a stretched valuation with a price-to-sales ratio north of 250x. Liquidity remains a bright spot, $7.2 million in cash on the balance sheet provides a buffer to fund further R&D and expansion.

Kinetik Holdings (KNTK), a midstream energy operator with a strong footprint in the Permian Basin, is seeing renewed investor attention after news that it will be added to the S&P SmallCap 600 index, replacing Pacific Premier Bancorp. Shares are up nearly 5% in premarket trading as index-tracking funds begin to position for the inclusion, which takes effect September 2.

Despite a 31% slide over the past month, KNTK offers a hefty 7.7% dividend yield and stable cash flows from its pipeline and gathering infrastructure. Index membership should boost liquidity, broaden ownership, and potentially help re-rate the stock, especially as energy remains a key market focus amid volatile oil prices.

Rigetti Computing (RGTI), a pure-play quantum hardware developer, continues to balance groundbreaking innovation with financial growing pains. The company unveiled its new 36-qubit “Cepheus-1” multi-chip processor in Q2, achieving record improvements in error reduction. But revenues slipped to just $1.8 million, down from last year, while net losses widened to nearly $40 million.

Despite these setbacks, Rigetti raised $350 million in fresh capital, boosting its cash reserves to $571 million and eliminating debt. Shares are down 28% year to date, but early Tuesday trading showed a 3% decline, a reminder of the stock’s volatility. Investors are now looking toward progress on its 100+ qubit roadmap, which could be pivotal in securing partnerships in cloud computing and government contracts.

Why settle for a “good” year when you could set yourself up for a great one?

Our analysts screened thousands of companies and narrowed them down to 5 stocks with the best chance to double.

These aren’t speculative guesses.

They’re based on:

In the past, this exact report uncovered stocks that soared as much as +175%, +498%, and +673%. ¹

You can get the new report instantly—but only until midnight tonight.

[Download your free copy here]

Don’t just play the market. Position yourself to win big.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.